These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6159904)

  • 21. Fenbufen and indomethacin: a comparative study in rheumatoid arthritis.
    Burton WD; Hazleman BL
    Clin Ther; 1983; 5(3):260-7. PubMed ID: 6342784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fenbufen in patients with gastric intolerance.
    Paice EW; Tookman AJ; White AG
    Eur J Rheumatol Inflamm; 1982; 5(3):301-3. PubMed ID: 7084291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical study of long term administration of fenbufen in rheumatoid arthritis].
    Soldati R; Sorbilli G; Di Benedetto P
    Clin Ter; 1980 Aug; 94(4):445-59. PubMed ID: 7460498
    [No Abstract]   [Full Text] [Related]  

  • 24. Single-dose pharmacokinetic study of 900 mg fenbufen in the elderly.
    Braverman AM
    Eur J Rheumatol Inflamm; 1982; 5(3):304-7. PubMed ID: 7084292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term safety of benoxaprofen.
    Mikulaschek WM
    J Rheumatol Suppl; 1980; 6():100-7. PubMed ID: 6993665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fenbufen based 3-[5-(substituted aryl)-1,3,4-oxadiazol-2-yl]-1-(biphenyl-4-yl)propan-1-ones as safer antiinflammatory and analgesic agents.
    Husain A; Ahmad A; Alam MM; Ajmal M; Ahuja P
    Eur J Med Chem; 2009 Sep; 44(9):3798-804. PubMed ID: 19457595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A six-month parallel group comparison of fenbufen and naproxen in the treatment of rheumatoid arthritis.
    Khan FM
    Clin Ther; 1983; 5(5):483-7. PubMed ID: 6352034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fenbufen: a review of its pharmacological properties and therapeutic use in rheumatic diseases and acute pain.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1981 Jan; 21(1):1-22. PubMed ID: 7009135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacologic properties of fenbufen.
    Kerwar SS
    Am J Med; 1983 Oct; 75(4B):62-9. PubMed ID: 6356910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of prostaglandin activity and synthesis by fenbufen (a new nonsteroidal antiinflammatory agent) and one of its metabolites.
    Tolman EL; Birnbaum JE; Chiccarelli FS; Panagides J; Sloboda AE
    Adv Prostaglandin Thromboxane Res; 1976; 1():133-8. PubMed ID: 826139
    [No Abstract]   [Full Text] [Related]  

  • 32. The acute action of fenbufen and piroxicam on the gastric mucosa as measured by gastric microbleeding.
    Collins AJ; Notarianni LJ
    J Int Med Res; 1984; 12(3):179-83. PubMed ID: 6610580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prescription-event monitoring. A preliminary study of benoxaprofen and fenbufen.
    Inman WH
    Acta Med Scand Suppl; 1984; 683():119-26. PubMed ID: 6234753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fenbufen: goes down well!
    Hopkins SJ
    Nurs Mirror; 1981 Dec; 153(23):53. PubMed ID: 6914665
    [No Abstract]   [Full Text] [Related]  

  • 35. Studies on an anti-inflammatory agent. III. Pharmacological investigations of a new non-steroidal anti-inflammatory agent: 2-oxo-3-[4-(1-oxo-2-isoindolinyl)-phenyl]-butanamide (GP 650).
    Fukawa K; Kanezuka T; Ohba S; Kawano O; Hibi M; Misaki N; Sawabe T
    Arzneimittelforschung; 1982; 32(3):225-30. PubMed ID: 6979341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pharmacological profile of 2-(8-methyl-10,11-dihydro-11-oxodibenz[b,f]oxepin-2-yl)propionic acid (AD-1590), a new non-steroidal anti-inflammatory agent with potent antipyretic activity.
    Nakamura H; Yokoyama Y; Motoyoshi S; Ishii K; Imazu C; Seto Y; Kadokawa T; Shimizu M
    Arzneimittelforschung; 1983; 33(11):1555-69. PubMed ID: 6607053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Severe vasculitis during treatment with fenbufen].
    Jean-Pastor MJ; Jean P; Garbe L; Andrac L; Lauret Y; Jouglard J
    Therapie; 1984; 39(3):305-9. PubMed ID: 6463955
    [No Abstract]   [Full Text] [Related]  

  • 38. Preclinical studies on indoprofen, a new non-steroidal analgesic-antiinflammatory agent.
    Buttinoni A; Tommasini R
    Eur J Rheumatol Inflamm; 1981; 4(1):3-10. PubMed ID: 6804240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute, subacute and chronic toxicity of oxepinac.
    Nomura M; Onodera T; Kato M; Yamada A; Ogawa H; Akimoto T
    Arzneimittelforschung; 1978; 28(3):445-51. PubMed ID: 580754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological properties of a new anti-inflammatory agent: 2-(2-isopropyl-5-indanyl)propionic acid (UP 517-03).
    Hertz F; Ranson M; Lwoff JM
    Arzneimittelforschung; 1980; 30(9):1549-57. PubMed ID: 6970037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.